Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cleary

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Cancer Research|April 2, 2017
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer ImmunotherapyDemin Li, Carol Bentley, Amanda Anderson, et al.
Current Oncology (Toronto, Ont.)|February 14, 2014
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statementP J Karanicolas, P Metrakos, K Chan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 20, 2021
A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant TherapyA M Elamir, S Hutchinson, H Albaba, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 27, 2025
Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ HybridizationCameron Beech, Diane M Wilcock, Kristina H Moore, et al.
Archives of Pathology & Laboratory Medicine|March 15, 2023
Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast CancerDiane M Wilcock, Kristina H Moore, Leslie Rowe, et al.
Cancer Immunology Research|September 26, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for ImmunotherapyKirstie L S Cleary, Monika Semmrich, Linda Martensson, et al.
Current Oncology (Toronto, Ont.)|January 5, 2017
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016D Bossé, T Ng, C Ahmad, et al.
Blood Advances|June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.
Immunity|November 18, 2018
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector FunctionSarah L Buchan, Lang Dou, Marcus Remer, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 8, 2022
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapyKhiyam Hussain, Rena Liu, Rosanna C G Smith, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Cancer Research|April 2, 2017
Development of a T-cell Receptor Mimic Antibody against Wild-Type p53 for Cancer ImmunotherapyDemin Li, Carol Bentley, Amanda Anderson, et al.
Current Oncology (Toronto, Ont.)|February 14, 2014
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statementP J Karanicolas, P Metrakos, K Chan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 20, 2021
A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant TherapyA M Elamir, S Hutchinson, H Albaba, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 27, 2025
Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ HybridizationCameron Beech, Diane M Wilcock, Kristina H Moore, et al.
Archives of Pathology & Laboratory Medicine|March 15, 2023
Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast CancerDiane M Wilcock, Kristina H Moore, Leslie Rowe, et al.
Cancer Immunology Research|September 26, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for ImmunotherapyKirstie L S Cleary, Monika Semmrich, Linda Martensson, et al.
Current Oncology (Toronto, Ont.)|January 5, 2017
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016D Bossé, T Ng, C Ahmad, et al.
Blood Advances|June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.
Immunity|November 18, 2018
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector FunctionSarah L Buchan, Lang Dou, Marcus Remer, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 8, 2022
HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapyKhiyam Hussain, Rena Liu, Rosanna C G Smith, et al.
Pageof 11